Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
NCT01318733
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
449
Enrollment
INDUSTRY
Sponsor class
Conditions
Rosacea
Interventions
DRUG:
CD07805/47 gel 0.5%
Sponsor
Galderma R&D